FILINGSINTEL

Forensic Analysis of Microcap and OTC Stock Filings

Evidence-based reviews of filings and disclosures. Focused on dilution, structure, and risk. No hype. No promotion. No price targets.

What this is

FilingsIntel provides structured forensic analysis of publicly disclosed information for microcap and OTC companies.

The work focuses on what is actually reported, how it changes over time, and where material risk, inconsistency, or dilution appears. This is not promotional research.

Analysis is limited to publicly disclosed information and does not include investment advice or recommendations.

View a sample forensic snapshot

View annotated filing excerpt (PDF)

What is covered

Coverage may include share structure changes and dilution, convertible notes and equity issuances, balance sheet and cash position, asset claims versus filings, disclosure gaps, reconstructed timelines from filings and press releases, and counterparty or related-party risk.

All findings are tied directly to source disclosures.

What you receive

A written report explaining the findings in clear, practical terms.

Material risks identified without technical jargon.

References to the underlying public disclosures.

A concise bottom-line assessment.

Who this is for

Investors who want to understand dilution risk, disclosure quality, and structural red flags using filings rather than narratives.

Who this is not for

Those seeking investment advice, trading recommendations, or price predictions.

Pricing

Quick Scan: $49

Focused Review: $89

1 filing period. Share structure, dilution mechanics, cash position, and key disclosure flags.

Full Forensic Review: $149

Flat fee. One-time service. Scope defined up front.

View a sample forensic snapshot

View annotated filing excerpt (PDF)

Turnaround

Most reports are delivered within 48 hours.

More complex reviews are delivered within 72 hours.

Process

After checkout, you complete a short intake form so the analysis can begin.

Scope and limitations

FilingsIntel does not provide investment advice, trading recommendations, ratings, or price targets.

FilingsIntel does not verify assets, operations, or third party claims.

Analysis is limited to what is disclosed in public materials at the time of review.

Start Order